Distress in Crisis Situations During COVID-19

Stress, Psychological Clinical Trial

Official title:

Distress During the COVID-19 Pandemic in France: a National Assessment of At-risk Populations

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04337047
• Other study ID #: WefightDistress20
• Status: Completed
• Start date: March 31, 2020
• Est. completion date: May 3, 2020

Study information

• Verified date: May 2020
• Source: Wefight
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

There are many scales for screening or assessing the impact of a disease. These scales are generally used to diagnose or assess the severity of a disease and are carried out at the request of a physician by the patient. Conversational agents could make it possible to administer these questionnaires remotely, analyse them and use the results on a large scale, without prior medical intervention.

The main objective of this study is to quantify and qualify the distress of a large population in times of pandemic crisis.

Description:

The Peritraumatic Distress Inventory is the standard tool designed to assess distress in times of crisis. It consists of 13 questions.

Questions will be submitted to the participants from the Vik chatbot. Responses will be analysed and compared according to the demographics and pathologies encountered.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2000
• Est. completion date: May 3, 2020
• Est. primary completion date: April 30, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age > 18 years old

• Collection of the subject's non-opposition

• Patient registration on Vik breast, Vik asthma, Vik migraine, Vik depression

Exclusion Criteria:

• Patient unable to formulate non-opposition

Related Conditions & MeSH terms

• Stress, Psychological

Intervention

Other:
• questionnaire assesment
questionnaire assesment

Locations

Country	Name	City	State
France	Wefight	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
Wefight

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	quantify and qualify distress over a large population in times of pandemic crisis.		1 month
Secondary	qualify demographic data vs distress over a large population in times of pandemic crisis.		1 month